COMPAGNIE CHARGEURS INVEST (CRI.PA) Stock Fundamental Analysis
EPA:CRI - Euronext Paris - Matif - FR0000130692 - Common Stock - Currency: EUR
We assign a fundamental rating of 3 out of 10 to CRI. CRI was compared to 14 industry peers in the Industrial Conglomerates industry. CRI has a bad profitability rating. Also its financial health evaluation is rather negative. CRI is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year CRI was profitable.
CRI had a positive operating cash flow in the past year.
Of the past 5 years CRI 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: CRI reported negative operating cash flow in multiple years.
1.2 Ratios
CRI has a Return On Assets of 0.72%. This is in the lower half of the industry: CRI underperforms 78.57% of its industry peers.
CRI has a worse Return On Equity (2.33%) than 78.57% of its industry peers.
CRI has a worse Return On Invested Capital (5.11%) than 71.43% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CRI is below the industry average of 7.10%.
The 3 year average ROIC (4.65%) for CRI is below the current ROIC(5.11%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.72% | ||
| ROE | 2.33% | ||
| ROIC | 5.11% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
1.3 Margins
The Profit Margin of CRI (1.00%) is worse than 85.71% of its industry peers.
CRI's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 6.54%, CRI is doing worse than 71.43% of the companies in the same industry.
CRI's Operating Margin has been stable in the last couple of years.
Looking at the Gross Margin, with a value of 28.34%, CRI is doing worse than 92.86% of the companies in the same industry.
In the last couple of years the Gross Margin of CRI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.54% | ||
| PM (TTM) | 1% | ||
| GM | 28.34% |
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
2. Health
2.1 Basic Checks
CRI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CRI has been increased compared to 1 year ago.
CRI has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CRI has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.49, we must say that CRI is in the distress zone and has some risk of bankruptcy.
CRI's Altman-Z score of 1.49 is on the low side compared to the rest of the industry. CRI is outperformed by 78.57% of its industry peers.
CRI has a debt to FCF ratio of 14.78. This is a negative value and a sign of low solvency as CRI would need 14.78 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 14.78, CRI is in line with its industry, outperforming 42.86% of the companies in the same industry.
CRI has a Debt/Equity ratio of 1.05. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.05, CRI is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.05 | ||
| Debt/FCF | 14.78 | ||
| Altman-Z | 1.49 |
ROIC/WACC0.73
WACC6.99%
2.3 Liquidity
A Current Ratio of 1.25 indicates that CRI should not have too much problems paying its short term obligations.
With a Current ratio value of 1.25, CRI is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
A Quick Ratio of 0.82 indicates that CRI may have some problems paying its short term obligations.
With a Quick ratio value of 0.82, CRI is not doing good in the industry: 78.57% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.25 | ||
| Quick Ratio | 0.82 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 1749.48% over the past year.
Measured over the past years, CRI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -14.59% on average per year.
Looking at the last year, CRI shows a quite strong growth in Revenue. The Revenue has grown by 11.85% in the last year.
The Revenue has been growing slightly by 3.10% on average over the past years.
EPS 1Y (TTM)1749.48%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%518.18%
Revenue 1Y (TTM)11.85%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%15.47%
3.2 Future
CRI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.06% yearly.
The Revenue is expected to grow by 6.76% on average over the next years.
EPS Next Y146.66%
EPS Next 2Y74.67%
EPS Next 3Y29.06%
EPS Next 5YN/A
Revenue Next Year9.12%
Revenue Next 2Y8.09%
Revenue Next 3Y6.76%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 33.81, which means the current valuation is very expensive for CRI.
Based on the Price/Earnings ratio, CRI is valued a bit more expensive than the industry average as 78.57% of the companies are valued more cheaply.
CRI's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.30.
The Price/Forward Earnings ratio is 9.93, which indicates a very decent valuation of CRI.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CRI indicates a somewhat cheap valuation: CRI is cheaper than 78.57% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, CRI is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.81 | ||
| Fwd PE | 9.93 |
4.2 Price Multiples
CRI's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRI indicates a somewhat cheap valuation: CRI is cheaper than 78.57% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.37 | ||
| EV/EBITDA | 7.27 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CRI's earnings are expected to grow with 29.06% in the coming years.
PEG (NY)0.23
PEG (5Y)N/A
EPS Next 2Y74.67%
EPS Next 3Y29.06%
5. Dividend
5.1 Amount
CRI has a Yearly Dividend Yield of 1.22%. Purely for dividend investing, there may be better candidates out there.
CRI's Dividend Yield is slightly below the industry average, which is at 3.68.
With a Dividend Yield of 1.22, CRI pays less dividend than the S&P500 average, which is at 2.37.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.22% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y74.67%
EPS Next 3Y29.06%
EPA:CRI (7/11/2025, 7:00:00 PM)
10.82
+0.1 (+0.93%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryIndustrial Conglomerates
Earnings (Last)
Earnings (Next)
Inst Owners9.98%
Inst Owner ChangeN/A
Ins Owners64.27%
Ins Owner ChangeN/A
Market Cap268.99M
Analysts75.56
Price Target13.73 (26.89%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.22% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.75%
PT rev (3m)-3.58%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.81 | ||
| Fwd PE | 9.93 | ||
| P/S | 0.37 | ||
| P/FCF | 9.37 | ||
| P/OCF | 6.04 | ||
| P/B | 0.86 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.27 |
EPS(TTM)0.32
EY2.96%
EPS(NY)1.09
Fwd EY10.07%
FCF(TTM)1.15
FCFY10.67%
OCF(TTM)1.79
OCFY16.54%
SpS29.35
BVpS12.61
TBVpS-0.27
PEG (NY)0.23
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.72% | ||
| ROE | 2.33% | ||
| ROCE | 6.99% | ||
| ROIC | 5.11% | ||
| ROICexc | 6.21% | ||
| ROICexgc | 14.36% | ||
| OM | 6.54% | ||
| PM (TTM) | 1% | ||
| GM | 28.34% | ||
| FCFM | 3.93% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
ROICexc(3y)5.7%
ROICexc(5y)7.48%
ROICexgc(3y)13.2%
ROICexgc(5y)17.03%
ROCE(3y)6.37%
ROCE(5y)7.53%
ROICexcg growth 3Y-6.3%
ROICexcg growth 5Y2.48%
ROICexc growth 3Y-7.54%
ROICexc growth 5Y-2.79%
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
F-Score7
Asset Turnover0.72
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.05 | ||
| Debt/FCF | 14.78 | ||
| Debt/EBITDA | 4.24 | ||
| Cap/Depr | 52.67% | ||
| Cap/Sales | 2.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 57.27% | ||
| Profit Quality | 393.15% | ||
| Current Ratio | 1.25 | ||
| Quick Ratio | 0.82 | ||
| Altman-Z | 1.49 |
F-Score7
WACC6.99%
ROIC/WACC0.73
Cap/Depr(3y)59.11%
Cap/Depr(5y)54.94%
Cap/Sales(3y)2.51%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1749.48%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%518.18%
EPS Next Y146.66%
EPS Next 2Y74.67%
EPS Next 3Y29.06%
EPS Next 5YN/A
Revenue 1Y (TTM)11.85%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%15.47%
Revenue Next Year9.12%
Revenue Next 2Y8.09%
Revenue Next 3Y6.76%
Revenue Next 5YN/A
EBIT growth 1Y84.88%
EBIT growth 3Y1%
EBIT growth 5Y4.32%
EBIT Next Year145.94%
EBIT Next 3Y48.76%
EBIT Next 5YN/A
FCF growth 1Y152.76%
FCF growth 3Y-17.92%
FCF growth 5Y170%
OCF growth 1Y253.45%
OCF growth 3Y-11.82%
OCF growth 5Y11.78%